155
New Mexico State University ranks 155th among universities in the Cure Innovation Index, situated in Las Cruces, New Mexico. Its performance is notably stronger in Market Translation and Entrepreneurial Readiness than in Research Capabilities, reflecting a profile oriented toward application and commercialization. The university supports biomedical entrepreneurship training and maintains an incubator and accelerator. Taken together, these elements describe an institution whose infrastructure for moving research toward commercial use is more developed than its aggregate research output ranking suggests.
New Mexico State University ranked below average for Research Capabilities, a measure of the foundational infrastructure and resources that enable an institution to conduct high-quality, innovative science. Out of the factors in this category, New Mexico State University fared best in Facilities/Equipment.
Learn MoreNew Mexico State University ranked below average for Entrepreneurial Readiness, a measure of whether the institution has built a supportive ecosystem for entrepreneurship and whether faculty are engaged in and incentivized toward commercial activity. Out of the factors in this category, New Mexico State University fared best in Ecosystem Support.
Learn MoreNew Mexico State University ranked below average for Market Translation, a measure of how effectively a research institution moves scientific discovery out of the lab and into real-world clinical and commercial applications. Out of the factors in this category, New Mexico State University fared best in Experienced TTO.
Learn More
From a pool of more than 6,000 institutions, the top 303 were ranked using two dozen indicators — from scientific foundation and lab infrastructure to patents, products, and partnerships — drawn from more than a dozen federal and commercial databases, an original audit of all institutions, and surveys of more than 3,300+ scientists, industry leaders, and biomedical experts.
Innovation isn't a single moment — it's an entire ecosystem. The Index evaluates institutions across two dozen indicators, grouped in three core domains that reveal the full picture of what it takes to turn groundbreaking science into real-world impact.
China has caught up to the United States on the volume of biomedical research, but American universities and research institutions still hold a wide lead on influence.
How a resource-constrained university built a top-15 translation engine — and what other institutions can learn from it.
With 27 institutions ranked among the country’s top biomedical innovators, New York’s research cluster spans the entire state, and outperforms nearly every other in the country.
As NIH funding shrinks and industry pulls back from early-stage science, universities are rethinking how discoveries move from the lab to the market.
